🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and assertions of rapid British shipping. Vendors market the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is worrisome and could result in individuals administering products of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Content Removal

Based on the social media company, the service has taken down violative material and prohibited related keywords and query recommendations. The company stated it was committed to maintaining the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.

After minutes of joining one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, posts display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company investigational product not yet approved … may subject users to possibly significant medical dangers”.